Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel strategy for AIDS reported by UCSF researchers

Oct. 11, 1996

HIV inhibited by chemokine antagonist

Oct. 11, 1996

Ingenol derivatives as anti-HIV agents

Oct. 11, 1996

Merck & Co. cleared to market protease inhibitor in EU

Oct. 11, 1996

Anti-HIV agents from Nippon Paper

Oct. 11, 1996

EU approval for Roche AIDS drug

Oct. 11, 1996

Anti-HIV agents from Department of Health & Human Services

Oct. 11, 1996

Gilead Sciences issues warning regarding Vistide

Oct. 4, 1996

Japanese patent coverage for NABI HIV immunotherapeutic

Oct. 4, 1996

New agent for CMV infection from Glaxo Wellcome

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...